More importantly, we found a significant negative correlation between NaCT and HIF1α expression in human HCC, suggesting that citrate can be potential therapeutic strategy preventing metabolic adaptation to hypoxic tumor. Here, SLC13A5 is linked to hepatocellular carcinoma.